최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.32 no.3, 2022년, pp.278 - 286
Li, Wenyu (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Yin, Fan (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Bu, Zixuan (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Liu, Yuying (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Zhang, Yongqing (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Chen, Xiabing (Institute of Animal Husbandry and Veterinary Science, Wuhan Academy of Agricultural Science and Technology) , Li, Shaowen (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Li, Lu (State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University) , Zhou, Rui (State Key Laboratory of Agricultural Microbiology, College of Vet) , Huang, Qi
Live bacterial vector vaccines are one of the most promising vaccine types and have the advantages of low cost, flexibility, and good safety. Meanwhile, protein secretion systems have been reported as useful tools to facilitate the release of heterologous antigen proteins from bacterial vectors. The...
1 Ding C Ma J Dong Q Liu Q 2018 Live bacterial vaccine vector and delivery strategies of heterologous antigen: a review Immunol. Lett. 197 70 77 10.1016/j.imlet.2018.03.006 29550258
2 Lin IY Van TT Smooker PM 2015 Live-attenuated bacterial vectors: Tools for vaccine and therapeutic agent delivery Vaccines (Basel) 3 940 972 10.3390/vaccines3040940 26569321
3 Jiang H Hu Y Yang M Liu H Jiang G 2017 Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium Immunobiology 222 730 737 10.1016/j.imbio.2017.01.007 28187901
4 Gopal GJ Kumar A 2013 Strategies for the production of recombinant protein in Escherichia coli Protein J. 32 419 425 10.1007/s10930-013-9502-5 23897421
5 Jia B Jeon CO 2016 High-throughput recombinant protein expression in Escherichia coli : current status and future perspectives Open Biol. 6 160196 10.1098/rsob.160196 27581654
6 Rosano GL Ceccarelli EA 2014 Recombinant protein expression in Escherichia coli : Advances and challenges Front. Microbiol. 5 172 10.3389/fmicb.2014.00172 24860555
7 Burdette LA Leach SA Wong HT Tullman-Ercek D 2018 Developing Gram-negative bacteria for the secretion of heterologous proteins Microb Cell Fact. 17 196 10.1186/s12934-018-1041-5 30572895
8 Anne J Economou A Bernaerts K 2017 Protein secretion in Gram-positive bacteria: From multiple pathways to biotechnology Curr. Top. Microbiol. Immunol. 404 267 308 10.1007/82_2016_49 27885530
9 Karlsson AJ Lim HK Xu H Rocco MA Bratkowski MA Ke A 2012 Engineering antibody fitness and function using membrane-anchored display of correctly folded proteins J. Mol. Biol. 416 94 107 10.1016/j.jmb.2011.12.021 22197376
10 Natale P Bruser T Driessen AJ 2008 Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms Biochim. Biophys. Acta 1778 1735 1756 10.1016/j.bbamem.2007.07.015 17935691
11 Palmer T Berks BC 2012 The twin-arginine translocation (Tat) protein export pathway Nat. Rev. Microbiol. 10 483 496 10.1038/nrmicro2814 22683878
12 Nicolay T Vanderleyden J Spaepen S 2015 Autotransporter-based cell surface display in Gram-negative bacteria Crit. Rev. Microbiol. 41 109 123 10.3109/1040841X.2013.804032 23855358
13 Cao Z Casabona MG Kneuper H Chalmers JD Palmer T 2016 The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria Nat. Microbiol. 2 16183 10.1038/nmicrobiol.2016.183 27723728
14 Akeda Y Kimura T Yamasaki A Kodama T Iida T Honda T 2012 Functional cloning of Vibrio parahaemolyticus type III secretion system 1 in Escherichia coli K-12 strain as a molecular syringe Biochem. Biophys. Res. Commun. 427 242 247 10.1016/j.bbrc.2012.09.018 22995311
15 Zhu C Ruiz-Perez F Yang Z Mao Y Hackethal VL Greco KM 2006 Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli Vaccine 24 3821 3831 10.1016/j.vaccine.2005.07.024 16098637
16 Xu C Zhang BZ Lin Q Deng J Yu B Arya S 2018 Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection BMC Infect. Dis. 18 195 10.1186/s12879-018-3104-y 29699491
17 Palmer T Stansfeld PJ 2020 Targeting of proteins to the twin-arginine translocation pathway Mol. Microbiol. 113 861 871 10.1111/mmi.14461 31971282
18 Alanen HI Walker KL Lourdes Velez Suberbie M Matos CF Bönisch S Freedman RB 2015 Efficient export of human growth hormone, interferon α2b and antibody fragments to the periplasm by the Escherichia coli Tat pathway in the absence of prior disulfide bond formation Biochim. Biophys. Acta 1853 756 763 10.1016/j.bbamcr.2014.12.027 25554517
19 Browning DF Richards KL Peswani AR Roobol J Busby SJW Robinson C 2017 Escherichia coli "TatExpress" strains super-secrete human growth hormone into the bacterial periplasm by the Tat pathway Biotechnol. Bioeng. 114 2828 2836 10.1002/bit.26434 28842980
20 Albiniak AM Matos CF Branston SD Freedman RB Keshavarz-Moore E Robinson C 2013 High-level secretion of a recombinant protein to the culture medium with a Bacillus subtilis twin-arginine translocation system in Escherichia coli FEBS J. 280 3810 3821 10.1111/febs.12376 23745597
21 Wang Y Yang W Wang Q Qu J Zhang Y 2013 Presenting a foreign antigen on live attenuated Edwardsiella tarda using twin-arginine translocation signal peptide as a multivalent vaccine J. Biotechnol. 168 710 717 10.1016/j.jbiotec.2013.08.018 23994481
22 Goyette-Desjardins G Auger JP Xu J Segura M Gottschalk M 2014 Streptococcus suis , an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing Emerg. Microbes Infect. 3 e45 10.1038/emi.2014.45 26038745
24 Segura M 2015 Streptococcus suis vaccines: candidate antigens and progress Expert Rev. Vaccines 14 1587 1608 10.1586/14760584.2015.1101349 26468755
25 Gao W Yin J Bao L Wang Q Hou S Yue Y 2018 Engineering extracellular expression systems in Escherichia coli based on transcriptome analysis and cell growth state ACS Synth. Biol. 7 1291 1302 10.1021/acssynbio.7b00400 29668266
26 Casadaban MJ 1976 Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu J. Mol. Biol. 104 541 555 10.1016/0022-2836(76)90119-4 781293
27 Qi LS Larson MH Gilbert LA Doudna JA Weissman JS Arkin AP 2013 Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression Cell 152 1173 1183 10.1016/j.cell.2013.02.022 23452860
28 Li Y Lin Z Huang C Zhang Y Wang Z Tang YJ 2015 Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome editing Metab. Eng. 31 13 21 10.1016/j.ymben.2015.06.006 26141150
29 Huang Q Alcock F Kneuper H Deme JC Rollauer SE Lea SM 2017 A signal sequence suppressor mutant that stabilizes an assembled state of the twin arginine translocase Proc. Natl. Acad. Sci. USA 114 E1958 e1967 10.1073/pnas.1615056114 28223511
30 Ize B Stanley NR Buchanan G Palmer T 2003 Role of the Escherichia coli Tat pathway in outer membrane integrity Mol. Microbiol. 48 1183 1193 10.1046/j.1365-2958.2003.03504.x 12787348
31 Li W Liu L Qiu D Chen H Zhou R 2010 Identification of Streptococcus suis serotype 2 genes preferentially expressed in the natural host Int. J. Med. Microbiol. 300 482 488 10.1016/j.ijmm.2010.04.018 20554247
33 Nhan NT Gonzalez de Valdivia E Gustavsson M Hai TN Larsson G 2011 Surface display of Salmonella epitopes in Escherichia coli and Staphylococcus carnosus Microb Cell Fact. 10 22 10.1186/1475-2859-10-22 21481238
34 Zhang J Shi Z Kong FK Jex E Huang Z Watt JM 2006 Topical application of Escherichia coli -vectored vaccine as a simple method for eliciting protective immunity Infect. Immun. 74 3607 3617 10.1128/IAI.01836-05 16714593
35 Jones B Pascopella L Falkow S 1995 Entry of microbes into the host: using M cells to break the mucosal barrier Curr. Opin. Immunol. 7 474 478 10.1016/0952-7915(95)80091-3 7495510
36 Rescigno M Rotta G Valzasina B Ricciardi-Castagnoli P 2001 Dendritic cells shuttle microbes across gut epithelial monolayers Immunobiology 204 572 581 10.1078/0171-2985-00094 11846220
37 Buttaro C Fruehauf JH 2010 Engineered E. coli as vehicles for targeted therapeutics Curr. Gene Ther. 10 27 33 10.2174/156652310790945593 20156190
38 Byrd W Ruiz-Perez F Setty P Zhu C Boedeker EC 2017 Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain Vet. Microbiol. 211 180 188 10.1016/j.vetmic.2017.10.006 29102116
39 Aguilera-Herce J García-Quintanilla M Romero-Flores R McConnell MJ Ramos-Morales F 2019 A Live Salmonella vaccine delivering PcrV through the Type III secretion system protects against Pseudomonas aeruginosa mSphere 4 e00116 19 10.1128/mSphere.00116-19 30996108
41 Frain KM Robinson C van Dijl JM 2019 Transport of folded proteins by the Tat system Protein J. 38 377 388 10.1007/s10930-019-09859-y 31401776
42 Huang Q Palmer T 2017 Signal peptide hydrophobicity modulates interaction with the twin-arginine translocase mBio 8 e00909 17 10.1128/mBio.00909-17 28765221
43 Tarry M Arends SJ Roversi P Piette E Sargent F Berks BC 2009 The Escherichia coli cell division protein and model Tat substrate SufI (FtsP) localizes to the septal ring and has a multicopper oxidase-like structure J. Mol. Biol. 386 504 519 10.1016/j.jmb.2008.12.043 19135451
44 Chen T Wang C Hu L Lu H Song F Zhang A 2021 Evaluation of the immunoprotective effects of IF-2 GTPase and SSU05-1022 as a candidate for a Streptococcus suis subunit vaccine Future Microbiol. 16 721 729 10.2217/fmb-2020-0232 34223787
45 Dumesnil A Martelet L Grenier D Auger JP Harel J Nadeau E 2019 Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infection BMC Vet. Res. 15 448 10.1186/s12917-019-2196-y 31823789
46 Jacobs AA van den Berg AJ Loeffen PL 1996 Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis Vet. Rec. 139 225 228 10.1136/vr.139.10.225 8883345
47 Zhang A Chen B Mu X Li R Zheng P Zhao Y 2009 Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2 Vaccine 27 1348 1353 10.1016/j.vaccine.2008.12.047 19150475
48 Zhou Y Wang Y Deng L Zheng C Yuan F Chen H 2015 Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2 Vaccine 33 2254 2260 10.1016/j.vaccine.2015.03.038 25820064
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.